Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
SID&GP will hold a workshop on computerized systems validation
Federal State-funded Institution "State Institute of Drugs and Good Practices" and Pharmstrategy, Ltd. will hold an open expert-advisory workshop on computerized systems validation.
SID&GP representatives participated in GEP-Russia 2018
On October 16, representatives of FSI "State Institute of Drugs and Good Practices" (SID&GP) took part in the GEP-Russia International Conference in Moscow (Russia).
SID&GP inspectors participated in training GMP inspection
On October 8 and 9, inspectors of the SID&GP together with their peers from Armenia and Kazakhstan took part in a mock GMP inspection at the Gideon Richter Chemical Plant in Budapest (Hungary).
SID&GP presented the inspection overview of foreign pharma manufacturers
Mr. Vladislav Shestakov presented a review of the results of inspections of foreign pharmaceutical manufacturers at the PharmMedCirculation 2018 conference.
SID&GP reported about the dynamics of pharma industry in the Moscow region
On October 2, 2018, the Dubna Special Economic Zone hosted a conference to support the development of the medical and pharmaceutical industry of the Moscow Region.
SID&GP participated in PIC/S Committee meeting
Tatyana Nikolko, Deputy Head of the Administration for Pharmaceutical Products Inspection and Evaluation took the floor with a presentation on the Russian GMP Inspectorate.
SID&GP and PHARMSTRATEGY held a workshop on validation of computerized systems
A joint educational project organized by the SID&GP of the Russian Ministry of Industry and Trade and PHARMSTRATEGY is aimed to promote the best practices in the Russian pharma industry.
CFDA representatives visited their Russian colleagues from the SID&GP
On September 24, 2018, a delegation from the Foods and Drugs Administration of Yunnan Province (China) visited the State Institute of Drugs and Good Practices.
Russia cements its friendly relations with Saudi Arabia
The Saudi Food and Drug Authority opened its annual conference in Riyadh. The Saudi Arabian pharmaceutical market is the largest in the Middle East and North Africa.
SID&GP presented results of manufacturers survey
Vladislav Shestakov took part in the meeting dedicated to labeling of pharmaceutical products where he discussed prospects of pharmaceutical labeling.
SID & GP took part in the International Conference of Drug Regulatory Authorities
Representatives of the Russian Ministry of Industry and Trade and the State Institute of Drugs and Good Practices participated in the International Conference of Drug Regulatory Authorities (ICDRA).
Master classes at the III All-Russia GMP conference hit the records
August 29 was the final day of the III All-Russia GMP conference with international participation Russia and the World. Management of the pharmaceutical market growth potential.
III All-Russia GMP-conference is being held in Kazan
The organizers of the III All-Russia GMP-conference, held in Kazan (Russia), are determined to provide environment for a bilateral dialogue, new business contacts and mastering new practices.
Russia and Bulgaria signed cooperation agreement
Last week in Sofia Vladislav Shestakov, Director of the State Institute of Drugs and Good Practices, Deputy Head of the State GMP Inspectorate met with Assena Stoimenova, Executive Director of the Bulgarian Drug Agency.
Results of the 2nd All-Russian Inter-University GxP Summit
The results of the 2nd All-Russian Inter-University GxP Summit with international participation “Selecting the Best: Time Forward” were summed up on July 6 in Sochi.
Conducting a joint training GMP-inspection
On June 4 and 5, 2018 employees of FSI “SID & GP”conducted a joint training GMP inspection with representatives of the regulatory entities of the Republic of Kazakhstan and the Kyrgyz Republic.
Page 3 of 4
Pharmasyntez Group of Companies
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
Active pharmaceutical substance for preparation of sterile and non-sterile drug products
Suitable for pharmaceutical oral & infusion formulations
Made in Germany
Prostaglandin derivatives for treatment of glaucoma
TOP 30 Pharmaceutical Contract Manufacturing Organisations
GMP Inspection Practice: a Case for Global Benchmarking, Con...
EAEU May Allow to Register Empty Primary Packages as Medical...
Regulation of Autogenous Vaccines
Inspection of Foreign Manufacturers of Veterinary Products
FDA Approved XCOPRI to Treat Partial-Onset Seizures
Subscribe to Newsletter!
© GMP news